|
시장보고서
상품코드
1559459
세계의 슬관절 재건 기기 - 시장 인사이트, 경쟁 구도, 시장 예측(2030)Knee Reconstruction Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
||||||
세계 슬관절 재건 기기 시장 규모는 2023년에 75억 4,000만 달러로 평가되었고 2030년까지 97억 8,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 4.52%의 성장이 예상됩니다. 시장은 변형성 관절증이나 류마티스 관절염과 같은 변성 골질환의 유행, 제품 개발/이노베이션 활동 증가 등의 주요 요인이 시장 성장에 기여해, 예측 기간 동안 큰 성장을 보여줍니다.
슬관절 재건 기기 시장 역학
세계보건기구(WHO)(2023년)에 따르면 전 세계적으로 3억 4,400만 명이 변형성 무릎 관절증을 앓고 있습니다. 이 중 골관절염 환자의 73%는 55세 이상, 60%는 여성입니다. 골관절염은 무릎 관절의 연골 파괴를 특징으로 하는 퇴행성 관절 질환으로, 통증, 경직, 가동 영역의 감소를 초래합니다. 이 질환은 종종 관절에 심각한 손상을 일으키며, 기능 회복과 증상 완화를 위해 인공 슬관절 치환술이 필요할 수 있습니다.
같은 자료에 따르면 1,300만 명이 류마티스 관절염을 앓고 있습니다. 류마티스 관절이되면 관절의 내벽이 염증을 일으켜 침식되어 연골과 뼈 파괴가 진행됩니다. 인공 슬관절 치환술(전체 치환술 또는 부분 치환술)은 손상된 관절면을 인공 장비로 대체하고 기능을 회복시켜 통증을 완화하기 위해 수행됩니다.
게다가 2023년 10월, Indian Spinal Injuries Centre(ISIC)는 로봇에 의한 인공 슬관절 치환술을 전문으로 하는 새로운 부문을 도입하여 인도의 정형외과 의료에 큰 진보를 가져왔습니다. 이 센터는 바르샤바에 본사를 둔 Zimmer Biomet의 Rosa Robotics Knee System을 전개했습니다.
규제 당국에 의한 승인이나 우에시 등의 제품 개발 활동의 활성화도, 슬관절 재건 기기 시장의 성장에 직면할 전망입니다. 예를 들어, 2024년 6월 구자라트에 본사를 둔 의료기기 제조업체 Meril은 자체 개발 수술용 로봇 기술 MISSO를 발표했습니다. 이 혁신적인 시스템은 인공 슬관절 대체술 시 의사를 실시간으로 지원하도록 설계되었으며, 수술 비용을 최대 66%까지 절감할 것으로 예상됩니다.
따라서 예측 기간 동안 위와 같은 요인이 상호작용하여 무릎관절 재건/치환 디바이스 시장을 견인할 것으로 예측됩니다.
그러나 임플란트와 관련된 신경과 혈관 손상, 출혈, 경도, 신경 손상으로 인한 마비, 약점, 통증 등은 슬관절 재건 기기 시장의 성장을 억제할 수 있습니다.
슬관절 재건 기기 시장의 부문 분석
슬관절 재건 기기 시장의 제품 유형 부문은 인공 슬관절 전치환술 시스템의 범주가 2023년 최대 시장 수익 점유율을 차지할 것으로 예측됩니다. 이 카테고리의 급성장은 심각한 무릎 관절염과 관절 장애를 치료하는 데 사용되는 고급 임플란트로 인한 것으로 간주됩니다. 인공 슬관절 전치환술은 코발트 크롬 합금과 초고분자량 폴리에틸렌과 같은 내구성 있는 재료로 만들어진 대퇴골, 경골, 슬개골의 세 가지 주요 구성요소로 구성되어 있습니다.
최신 인공 슬관절 전치환술 시스템은 맞춤형 크기 조정, 모듈 설계, 컴퓨터 지원 네비게이션 및 로봇 지원과 같은 첨단 기술을 특징으로 하며, 정확한 임플란트 임베디드 및 치료 성적 향상을 보장합니다. 이러한 혁신은 관절 기능을 높이고 통증을 줄이고 회복을 가속화함으로써 환자의 QOL을 크게 향상시킵니다.
또한, 제품 개발 활동 증가가 이러한 시장을 확대하고 있습니다. 예를 들어 2024년 5월, 수술기술의 혁신으로 산업을 선도하는 OrthAlign, Inc.는 회사의 주력 제품인 「Lantern」을, 일본에서 인공 슬관절 전치환술용으로 발매하는 것을 발표했습니다. 이 발매를 지원한 것은 2013년부터 시장에서 OrthAlign의 대리점을 맡아 6만 8,000건 이상의 OrthAlign 사례를 지원해 온 오랜 상업 파트너입니다.
따라서 광범위한 기능과 용도를 가진 인공 슬관절 전치환술 시스템 카테고리의 견고한 제품 포트폴리오의 존재는 상당한 성장을 보일 전망이며 결과적으로 2024-2030년의 예측 기간 동안 슬관절 재건 기기 시장 전체 성장에 기여할 전망입니다.
이 보고서는 세계 슬관절 재건 기기 시장에 대한 조사 분석을 통해 각 지역 시장 규모와 예측, 지난 3 년간의 제품/기술 개발, 각 부문의 성과 및 전망 등의 정보를 제공합니다.
Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing number of bone-related disorders and the rising product developmental activities across the globe
The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030. The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative bone conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, thus contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Knee Reconstruction/Replacement Devices Market Dynamics:
According to the World Health Organization (2023), 344 million individuals are affected by osteoarthritis globally. Among this population, 73% of people living with osteoarthritis are older than 55 years, and 60% are female. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage in the knee joint, leading to pain, stiffness, and reduced range of motion. This condition often results in significant joint damage that may necessitate knee replacement surgery to restore function and alleviate symptoms.
As per the same source, 13 million people are living with rheumatoid arthritis. This causes the joint lining to become inflamed and eroded, leading to progressive destruction of the cartilage and bone. Knee replacement surgery, either total or partial, is used to replace the damaged joint surfaces with prosthetic components, restoring function and alleviating pain.
Moreover, in October 2023, The Indian Spinal Injuries Centre (ISIC) introduced a new department dedicated to robotic knee replacement surgery, marking a significant advancement in orthopedic care in India. The center deployed the Rosa Robotics Knee System from Zimmer Biomet, based in Warsaw.
Increased product developmental activities such as approvals by the regulatory bodies and launches are also slated to witness the market growth of knee reconstruction/replacement devices. For instance, in June 2024, Meril, a Gujarat-based medical devices company, introduced its indigenously developed surgical robotic technology, MISSO. This innovative system was designed to assist doctors during knee replacement surgeries in real-time and was expected to reduce the cost of these procedures by up to 66 percent.
Hence, the interplay of all the above mentioned factors are expected to drive the market for knee reconstruction/replacement devices during the given forecast period from 2024 to 2030.
However, nerve and blood vessel injury, bleeding, and stiffness associated with implants, nerve damage can cause numbness, weakness and pain and others may restrain the growth of the Knee Reconstruction/Replacement devices market.
Knee Reconstruction/Replacement Devices Market Segment Analysis:
Knee Reconstruction/Replacement Devices Market by Product Type (Total Knee Arthroplasty Systems, Partial Knee Arthroplasty Systems, and Knee Revision Systems), Implant Type (Fixed Tibial Bearing Implants, Mobile Tibial Bearing Implants, and Medial Pivot Implants), Fixation (Cemented and Cementless), End-User (Hospitals, Orthopedic Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the knee reconstruction/replacement devices market, the total knee arthroplasty systems category is predicted to account for the largest market revenue share in 2023. The rapid growth of this category can be attributed due to advanced implants used to treat severe knee arthritis or joint disorders. They consist of three main components-femoral, tibial, and patellar parts, made from durable materials like cobalt-chromium alloys and ultra-high molecular weight polyethylene.
Modern total knee arthroplasty systems feature customizable sizing, modular designs, and advanced technologies such as computer-assisted navigation and robotic assistance to ensure precise implant placement and improved outcomes. These innovations enhance joint function, reduce pain, and accelerate recovery, significantly improving patients' quality of life.
Additionally, the rising product developmental activities increases the market for these. For example, in May 2024, OrthAlign, Inc., a leading innovator in surgical technology, announced the launch of its flagship product, Lantern, in Japan for total knee arthroplasty. The launch was supported by its longstanding commercial partner, who had represented OrthAlign in the market since 2013 and had supported over 68,000 OrthAlign cases.
Therefore, the presence of a robust product portfolio for the total knee arthroplasty systems category with a wide range of features and applications is expected to witness considerable growth, eventually contributing to the growth of the overall knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall knee reconstruction/replacement devices market:
Among all the regions, North America is expected to amass the largest share of the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.
According data from the American Academy of Orthopaedic Surgeons in 2024 stated that over 700,000 total knee replacement surgeries are performed each year in the US. In addition to this, recent updates provided by the Arthritis Society Canada (2022), stated that 1 million Canadians were affected by gout, which is the most common form of inflammatory arthritis. Gout predominantly impacts males more than females, with approximately 4% of men and 1% of women affected. Among the various joints that can be affected, the knee joint is the most commonly involved. Knee replacement and reconstruction surgeries are crucial for managing severe knee pain and dysfunction caused by conditions like arthritis and gout. These procedures are especially important for patients whose knee joints are significantly affected, offering relief from pain and improved mobility by replacing damaged joints with artificial ones.
The product developmental activities by regulatory bodies in the region also push forward the revenue shares of knee reconstruction devices. For example in July 2024, Globus Medical, Inc. announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex(TM) with Total Knee Arthroplasty (TKA) application. This new robotic navigation platform was added to the already best-in-class Excelsius(TM) ecosystem, designed to provide surgeons with enhanced control, resection accuracy, and procedural flexibility in Total Knee Arthroplasty. Additionally, the ACTIFY(TM) 3D Total Knee System, the latest in implant technology designed to pair with ExcelsiusFlex(TM), also received 510(k) clearance.
Moreover, the presence of key players such as Zimmer Biomet, Stryker, Johnson & Johnson Services, Inc, Exactech, Inc., and others in the region is also a driving factor for the knee reconstruction/replacement devices market as they hold significant revenue shares.
Thus, all the factors mentioned above promote a conducive environment for the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Knee Reconstruction/Replacement Devices Market key players:
Some of the key market players operating in the Knee Reconstruction/Replacement Devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc, Johnson & Johnson Services, Inc, Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.
Recent Developmental Activities in the Knee Reconstruction/Replacement Devices Market:
Key Takeaways from the Knee Reconstruction/Replacement Devices Market Report Study
Target audience who can be benefited from this Knee Reconstruction/Replacement Devices Market Report Study
Frequently Asked Questions for the Knee Reconstruction/Replacement Devices Market:
The knee reconstruction/replacement devices are devices designed to replace cartilage and bone which is damaged from musculoskeletal disease or aging. There are various replacement devices such as total knee arthroplasty systems, and partial knee arthroplasty systems, among others.
The knee reconstruction/replacement devices market was valued at USD 7.54 billion in 2023, growing at a CAGR of 4.52% during the forecast period from 2024 to 2030 to reach USD 9.78 billion by 2030.
The knee reconstruction/replacement devices market is experiencing significant growth owing to the widespread instances of degenerative conditions like osteoarthritis and rheumatoid arthritis, the rise in product development & innovation activities, among others that are acting as key factors, contributing to the market growth of the knee reconstruction/replacement devices market during the forecast period from 2024 to 2030.
Some of the key market players operating in the Knee Reconstruction/Replacement devices market include Zimmer Biomet, Stryker Corporation, Smith & Nephew, Exatech Inc., Johnson & Johnson Services, Inc., Corin, Microport Scientific Corporation, Conformis, B. Braun Melsungen AG, Medacta International, DJO Global, United Orthopedic Corporation, Meril Life Sciences Pvt. Ltd, and others.
Among all the regions, North America is estimated to hold a significant revenue share in the knee reconstruction/replacement devices market. This can be ascribed to the high incidence of knee-related conditions such as arthritis and gout, advancements in surgical technology and robotic navigation systems, as well as the presence of leading market players driving innovation in knee reconstruction and replacement. Collectively, these factors are expected to drive the demand for knee reconstruction and replacement devices throughout the forecast period from 2024 to 2030.